Litigation
Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
Johnson & Johnson Is in the News, but How Do the Charts Look?
I am not focused on today's price movement of the stock but the pattern from the end of 2017.
Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon
Understanding yourself and the investing environment you are in are keys to avoiding panic brought on by fear.
Why Wall Street Is Still Riding With Uber
Uber's crash on earnings does not mean the stock is totaled according to analysts covering the stock.
NL Industries Enjoys Big Day in the Sun After Lawsuit Cloud Lifts
Announcement of a settlement of a lead paint legal tussle that had gone on for nearly two decades gave NL shares a boost Thursday.
CannTrust Is Caught in a Cannabis Catch-22
The loss of clients is a primary concern here.
Boeing's Bad News Spills Over to Broad Supply Chain
Turbulence with Boeing's MAX jets jolts suppliers.
Boeing Loses Altitude as FAA Finds More Risks Related to 737 MAX
The Federal Aviation Administration has declined to set a timeline on when it will lift its order prohibiting the troubled aircraft from flying.
Charts of the Day: The States of U.S. Gambling
A bit of context to simmer on following the big deal between Caesars and Eldorado.
Jim Cramer: A Tale of Two Stocks
I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.